Lucentis (ranibizumab)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lucentis (ranibizumab), covering 2015-12-29 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm [Phase 3]